AB
Aurobinda Banerjee
About Aurobinda Banerjee
Data last updated:
Aurobinda Banerjee has 8 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Novorel Medical Devices Private Limited and Novo Medix Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2.56 Cr; the largest is Novo Medix Pharmaceutical Private Limited at ₹2.52 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novo Medix Pharmaceutical Private Limited U85100WB2020PTC235666 | Whole-Time Director | 03 Jan 2020 | 2020 | ₹2.52 Cr (FY 2025) | Active |
| Novorel Medical Devices Private Limited U33209WB2018PTC226538 | Director | 12 Jun 2018 | 2018 | ₹0.04 Cr (FY 2021) | Active |
| Feminova Pharmaceuticals Private Limited U85100WB2021PTC244307 | Director | 01 Apr 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aurobinda Banerjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurobinda Banerjee
Aurobinda Banerjee has 8 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Novorel Medical Devices Private Limited and Novo Medix Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2.56 Cr; the largest is Novo Medix Pharmaceutical Private Limited at ₹2.52 Cr (FY 2025).
Aurobinda Banerjee is associated with 3 companies as Director and Whole-Time Director, including Novo Medix Pharmaceutical Private Limited (₹2.52 Cr), Novorel Medical Devices Private Limited (₹0.04 Cr), Feminova Pharmaceuticals Private Limited.
Aurobinda Banerjee has expertise in General Business.
Aurobinda Banerjee has 8 years in corporate governance.
By reported revenue, the largest current company of Aurobinda Banerjee is Novo Medix Pharmaceutical Private Limited, with revenue of ₹2.52 Cr (FY 2025).
The 2 current companies of Aurobinda Banerjee that report revenue have a combined latest revenue of ₹2.56 Cr.
Aurobinda Banerjee currently holds positions at 3 companies: Novo Medix Pharmaceutical Private Limited (₹2.52 Cr), Novorel Medical Devices Private Limited (₹0.04 Cr), Feminova Pharmaceuticals Private Limited.